AbbVie ABBV
NYSE ABBV
$255.00 +4.09 (+1.63%)
As of: Sep 10, 2026 · 3:59 PM EDT

AbbVie (ABBV) Dividends Paid - Common (2013 - 2026)

AbbVie's (ABBV) quarterly Dividends Paid - Common came in at $3.1 billion in Q2 2026, up 5.5% year-over-year from $2.9 billion in Q2 2025, and down 0.52% quarter-over-quarter from $3.1 billion in Q1 2026.

Analysis

AbbVie (ABBV) Dividends Paid - Common (2013 - 2026) Analysis & Trends

AbbVie (ABBV) has reported Dividends Paid - Common for 14 consecutive years, with $3.1 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Dividends Paid - Common rose 5.5% year-over-year to $3.1 billion in Q2 2026; TTM through Jun 2026 was $12.0 billion, a 5.64% increase from a year earlier, with the FY2025 full-year figure at $11.7 billion, up 5.73% from the prior year.
  • Dividends Paid - Common was $3.1 billion for Q2 2026 at AbbVie, down from $3.1 billion in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $3.1 billion in Q1 2026 and troughed at $2.5 billion in Q3 2022.
  • A 5-year average of $2.7 billion and a median of $2.8 billion in 2024 frame the typical range for Dividends Paid - Common.
  • Across the five-year window, Dividends Paid - Common rose 8.79% in 2022 and increased 4.17% in 2024, its largest moves.
  • Over 5 years, Dividends Paid - Common stood at $2.5 billion in 2022, then grew by 4.79% to $2.6 billion in 2023, then increased by 4.8% to $2.8 billion in 2024, then climbed by 5.78% to $2.9 billion in 2025, then grew by 5.46% to $3.1 billion in 2026.
  • The last three Dividends Paid - Common figures came in at $3.1 billion (Q2 2026), $3.1 billion (Q1 2026), and $2.9 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 3.23 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 3.07 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 2.14 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -2.87 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 2.45 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 6.09 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.07 Bn
Mar 31, 2026 3.09 Bn
Dec 31, 2025 2.91 Bn
Sep 30, 2025 2.91 Bn
Jun 30, 2025 2.91 Bn
Mar 31, 2025 2.93 Bn
Dec 31, 2024 2.75 Bn
Sep 30, 2024 2.75 Bn
Jun 30, 2024 2.75 Bn
Mar 31, 2024 2.77 Bn
Dec 31, 2023 2.63 Bn
Sep 30, 2023 2.63 Bn
Jun 30, 2023 2.63 Bn
Mar 31, 2023 2.66 Bn
Dec 31, 2022 2.51 Bn
Sep 30, 2022 2.50 Bn
Jun 30, 2022 2.51 Bn
Mar 31, 2022 2.53 Bn
Dec 31, 2021 2.31 Bn
Sep 30, 2021 2.32 Bn